Extract from Meningitis.org
“FAMILIES affected by meningitis are urging the Government to make a lifesaving new vaccine against Meningitis B – one of the deadliest forms of the disease – available to all children in the UK.
The vaccine, Bexsero, developed by pharmaceutical giant Novartis, received its marketing licence from the European Commission today.
It is the first Meningitis B vaccine to be licensed for use in the UK and will save thousands of lives, especially among children under five, who are most at risk from the disease.
Meningitis B is a major issue for the UK, which has one of the highest incidence rates in the world. It is the most common form of meningitis in the UK, affecting an average of 1,8702 people each year, many of them children. One in 103 people who contract the disease will die and one in four, will be left with life-changing after-effects, such as brain damage or limb loss.